ABCL

NoOneMan79

Looks like an ok pick with sustained retail pressure. I'm not seeing anything squeezey happening yet (SI rising could be a setup). Also, no real pump and no real dump either. Just a good stock pick. Im happier with my ABCL hold, but neither is a squeeze yet. Maybe there will be a catalyst next week or beyond?

NoOneMan79

Yeah, looks like an ok pick so far. Im still a bit happier with holding ABCL. But neither are a squeeze. Learn to read a chart. The short interest is at a yearly low [https://finviz.com/stock?t=RR&p=d&ty=si](https://finviz.com/stock?t=RR&p=d&ty=si) So...yeah. Learn to read anything.

34motox34

Hey y'all, anyone keeping an eye on ABCL? Its been making moves since their positive top-line results on one of their drugs.

34motox34

Thoughts on ABCL?

Inevitable-Poetry447

Trimmed ABCL today, will buy more around $8 as it consolidates down after 200M share issuance

pumukl

ABCL all in!

Eastern-Contact-2034

ABCL to $100 pls

NoOneMan79

6% is a squeeze? :) Let's wait for EOD tomorow, but congrats if so. Still not too sad about it. Glad Im a couple hundred shares into ABCL instead. :)

SummitSloth

Why is no one talking about ABCL

Bushman_22

ABCL

j_b_1983

Anyone else playing ABCL at open?

Significant-Lunch681

ABCL - biotech withpositive readout this morning. High short intrest. But better hurry….

VolcanicCupid69

ABCL is my new best friend. Great phase 2 results this am.

VolcanicCupid69

ABCL up 17% Friday. I am either going to the moon with my 60+ calls with the pre-market phase 2 result call, or to the earth’s core. Wish me luck.

CivilizedSteve

Good one thx hasn’t looked at it. This is exactly what I’m talking about I’m also looking at **Absci (ABSI)** **AbCellera (ABCL)**

mattbladez

hope you held now that it's stabilizing between 7-8$, and ABCL 635 results aren't even in yet!

anonkota

ABCL is about to rip so hard

anonkota

$ABCL going UP

anonkota

$ABCL going crazy

throwaway2676

This time it was ABCL and ABSI. Bought under $4, sold around $6

skiezovb

get in ABCL before its too late

AbbreviationsReal330

Ill add some more color to the conversation In short, I agree with the OP. \#1 research baker bros. It’s one of the most successful bio tech hedge funds. They only take large positions, they sit on multiple boards, and they are known for their due diligence, patience, and conviction. Look into their recent buys of ABCL and their overall position - research baker bros as well as their position in ABCL and then develop your own thoughts here… \#2 ABCL 635 - it’s for menopause VMS. Currently the competitor veozah does aprox 300M annually in revenue (it comes with a black box warning). ABCL 635 as of now - has not shown any hepatoxicity even at high doses, thus it likely won’t carry a black box warning. In my napkin math - I assume ABCL if/when it reaches the market, it could steal all the market share and even generate up to 1B annually in sales. In a potential best case scenario they could achieve this in aprox. 3-4 years (maybe earlier, maybe later). But the stock would likely re rate based on successful phase 2 data due Q3 of this year. A reasonable valuation after successful phase 2 data in my opinion, would be 5-10billion. Current market prices are sitting at about 2billion valuation. Now if the company ever achieves 5 billion in annual revenue (achievable in my opinion, if what’s in the current pipeline is successful) and it trades at a 5-7 multiple - we are talking a 25-30 billion valuation. I like the CEO, I like the company, I like the pipeline. And my position is aligned with my conviction. (Not investment advice, just my individual opinions and research)

Fearmo

Arsenal pianist was right again with ABCL. (i believe he called) sky rocketed.

arsenal_pianist

I'm long on ABCL and LXRX.

arsenal_pianist

FYI: for those interested in a long, I'm long on $ABCL Already made great gains before the latest pullback below $6. I'm expecting big moves based on some short term catalysts (possibly as soon as tomorrow). I consider anything under $5.75 a great entry.

Kitchen-Assist-6645

$ABCL and chill

Kitchen-Assist-6645

ABCL going for the moon today

tke248

Agree I have been focusing on drug discovery for my next wave like ABCL and TEM it will take a while but if they get drugs FDA approved in the pipeline the fly wheel should just keep getting better for them.

Dangerous-Berry7399

Solid DD, ABCL is legitimately underreacted to for a binary event this size. Been running stuff like this through StrikeEdge io lately — it surfaces deep OTM LEAPS setups before they pop, caught a RXRX call that went from $0.01 to $0.26 last month. The asymmetry on a Phase 2 miss vs. hit here is exactly the kind of risk profile that prints on cheap calls. What strike and expiry are you eyeing?

LazyItem

ABCL is interesting. Been long since Covid craze and they proved their underlying platform with rapid antibody development.

shaqballs

Yes had so it’s basically irrelevant now if not a bearish signal lol. I prefer ABCL for drug discovery companies but it’s already run up heavy. RXRX has potential but high risk.

Mrk0k0

Yessir. $ABCL, $ABSI, $GENB

Difficult_Teach_2930

$ABCL biotech

MessyKerbal

In all seriousness, I think ABCL is one of these stocks, but it’s a long term play

WestReflection7097

Buy $40 of ABCL don’t look at it and come back in 5 years.

throwaway2676

Yeah, a decent chance biotech is the next phase of the AI play. I’ve got some nice positions in peptides/antibodies (ABCL/ABSI) and gene therapies (CRSP/BEAM/PRME). Also RXRX as a pure AI biotech play

Mrk0k0

Biotech: ABCL, ABSI, GENB, RXRX

SkepticalInvestor21

This looks like legitimate biotech DD rather than a scam concern. ABCL is a real company with a genuinely interesting antibody discovery platform. The hantavirus angle is interesting if they're partnering on an outbreak response - that kind of government/emergency health work can accelerate timelines significantly. Key questions: is this a signed contract or an MoU, what's the total contract value, and does it materially change their revenue trajectory? Biotech catalyst plays require close reading of the actual contract terms.

Findingfairways

AbCellera. ABCL.

um877

ABCL

um877

ABCL is my next act. RKLB was my first masterpiece.

Ccjgaara

ABCL to the moon

GarageDoorGuide

Hantavirus Tracker: https://www.arcgis.com/apps/dashboards/5c68442d2afc42d7ba2696e4cd393729 Hantavirus biotechnology names: $MRNA $54.35 $INO $1.46 $TRAW $2.18 $EBS $9.50 $NVAX $10.11 $SABS $4.11 $ABCL $5.24

GarageDoorGuide

Hantavirus related stocks and the closing prices as of May 8th: $MRNA $54.35 $ABCL $5.24 $NVAX $10.11 $INO $1.46 $TRAW $2.18 $EBS $9.50 $SABS $4.11 Hantavirus Tracker: https://www.arcgis.com/apps/dashboards/5c68442d2afc42d7ba2696e4cd393729

GarageDoorGuide

Hantavirus Tracker: https://www.arcgis.com/apps/dashboards/5c68442d2afc42d7ba2696e4cd393729 Hantavirus related stocks and the closing prices as of May 8th: $MRNA $54.35 $ABCL $5.24 $NVAX $10.11 $INO $1.46 $TRAW $2.18 $EBS $9.50 $SABS $4.11 Missing any important names?

flumydumdum

Hantavirus will not lead to an epidemic. It's been around for ages. I did get into ABCL though mostly for the shortsqueeze potential. HIMS at \~$25 is just a good long-term play in general (5 year support)

ai-moderator

#TLDR --- Ticker: ABCL Direction: Up Prognosis: Buy/Hold Shares (OP is holding 8,000 shares at $4.25) Catalyst: May 11 Phase 1 Data Readout (ABCL635) Face-Melting Risk: High ("Biotech can vaporize your face") Summary: AbCellera is shedding its "post-COVID SPAC corpse" reputation and transitioning into a clinical-stage biotech with a massive $700M cash runway. The May 11 earnings call is less about the financials and all about the interim Phase 1 data for their lead program (ABCL635 for hot flashes). This is the first real test to see if their AI antibody discovery machine can actually produce viable drugs.

mattbladez

ABCL. They have a molecule in clinical trial that would be the first non-hormonal drug for menopausal hot flashes. They have lots of other things in the works but this is the shortest term potential that could be huge. Phase 2 readout is later this year.

Baucha_

IONQ, ABCL y IBRX... ah, y retomando HIMS

alquix

Consider PLUG. It’s close to your price range. Another one with potential is ABCL.

asdfadffs

ABCL, it’s either 10x or 0x

ralphy1010

I bought some NVidia back when it split and again last year in april when the market freaked out over trumps bs. Just been holding those since. ABCL is one i've been putting money into

cubbfan19

$ABCL

Charming_Party_2052

AMZN - mainly because of their focus/investment in Robotics GOOG - youtube, AI, is undervalued right now UBER - innovative AUR - almost a leader in autonomous driving (future of trucking) BULL - massive upside, sitting on tons of cash and growing SMCI - i dont really believe in it and I think margin is a problem with them but they have significant upside. Undervalued right now RXRX - innovative, could be big in future ABCL - same reasons Hyundai HYMTF - they own boston dynamics - not easy to invest in this if youre in North America

Wide_Marsupial2902

VXRT. Risk reward here, the price is beat down, trading off exchange but has potential to go big if their vaccine tech gets to market or bought up. ABCL is if their AI drug discovery proves out will be a royalty/revenue generator but its still early. They have a healthy cash runway. Its a buy and hold for growth in the future.

get_lit_420

I like ABCL for a bio play

duboilburner

I've been in $ABCL (AbCellera) for awhile now. Interesting biotech company using, for lack of better terms, a sort of AI to help them accelerate finding new treatments and drugs. Peter Thiel was an early investor, probably before they went public. I think he sold a chunk of what he had, though. It's currently around $3. Its lows are just under $2. Insiders have been buying more shares when we get to lows like that. They've had some on and off again contracts with some bigger drug companies that worked out pretty well. Pretty quiet at the moment, though. I do know they have a drug going through trials right now. 5-10 years from now, it has the potential to really go crazy at some point, I just don't know when. So, I keep chucking a little bit at it here and there. Its IPO was in 2021, so, the insiders/private equity that wanted to get out I think have done so by this point. The long term chart has the appearance of having found its ultimate lows. We may be setting a higher low from the most recent bottom now. It did go above $6 last fall. Seems to be the range for the time being, $2 to $6. Might continue to bounce around this range for a couple more years for all I know, but I do think eventually it runs hard. Outstanding shares is just under 300 million last I checked. So, not exactly a low float stock capable of truly wild stuff, but still small enough that if they get something that provides for great, continued revenue growth, it can still run quite a bit. Smaller OS than $MRNA, which eventually found itself in the $400 range in 2021... Just shy of $50 right now.

Optioneer_Official

I tend to look more at smaller / less crowded names rather than the obvious mega caps. A few I own (higher risk, obviously): LFMD – Telehealth / men’s health. I like the direct-to-consumer model and the margin expansion story if they keep scaling efficiently. Not saying it’s risk-free, but if they execute, it can re-rate. ABCL – AI-driven antibody discovery. This one is more of an asymmetric bet for me. If their platform consistently produces viable drug candidates and partnerships convert, upside could be significant. Still very biotech-risk heavy. GAMB – Gambling.com Group. Asset-light affiliate model in online betting. Solid cash generation and operating leverage if the U.S. market continues expanding state by state. CRMD – Small-cap biotech with a commercial product (DefenCath). This is more of a “commercial ramp” thesis. If adoption grows steadily, it could surprise people. If not, it’s dead money. All of these are volatile and definitely not “sleep well at night” positions — but that’s kind of the tradeoff for looking outside the usual Google/Amazon names. Just my approach.

throwaway2676

Yup, I've started going into gene therapy (e.g., CRSP, BEAM) and antibody/peptide design companies (e.g., ABSI, ABCL, GMAB) myself

RedbullOracleRacing

dude did you sell ABCL?

KinklyGirl143

OPTT, hoping it goes on sale tomorrow so I can jump back in. I did well with GSAT, in at $1.83 pre reverse split. ABCL has done well for me, they have a nice cash runway and they are in a phase 2 drug trial. Price is down right now, I’ll add some shares if it falls a bit more.

Itsyournamebackwards

When I’m losing conviction it’s either time to get out or rethink strategy if it’s still correct and if so push through. That’s why I am relocating some of my capital to biotech: $IBRX, $TMDX, $ABCL and $OPEN. Each a unique moat: from solving cancer without chemo, Tesla algorithm applied to organ transplant market, palentir for biotech and a market-maker/insurance company for the housing market run by one of the best upcoming CEOs in the world. You can find it on my X @BigShort24

skiezovb

ABCL will pop this year when their trial results are in in summer

skiezovb

Yessir! Really carried my portfolio last year. There is still a lot of potential upside if they get a nasdaq listing. Im excited for what the future holds. Also, I think ABCL will have a good year.

REfresh619

ABCL baby

Appropriate_Exit_206

Thankful to get out of ABCL with some profits. Since I sold it’s gone down below my entry price. I just had a feeling. I will never invest in biotech or pharma

transsisterradio

Wonder why ABCL was up today then

SystemsCapital

ABCL

Rnd1337_

My focus is on long-term investment, so my core position is the FTSE All-World (VWCE). The rest is therefore more risky conviction picks as a potential boost for the next 5-10 years: KRKNF, RKLB, ASTS, ONDS, NBIS, IREN, LAES, ABCL, PRME

Plane-Salamander2580

Context matters. Do you have $20-25 because you're dirt poor/low earnings and that's all you can save up? Or do you view the $20-25 as FU money and you've got enough saved aside as emergency funds to save yourself if needed? If it's the former, just VT and forget about it. If it's the latter, go ahead and buy some that fall between moonshots and and stable growth (Don't buy dumb shit like KULR, IPST, BYND. Consider stuff like POET, ABCL, RKLB, ASTS when they were pennies.)

trayber

ABCL

SummitSloth

$ABCL

Key-Acanthisitta7993

AI medicine, because they are going to run out of hyped up stocks: RXRX ABCL SDGR ABSI

Ok-Adeptness6444

VRCA, CAPR, VIR, LUNG... maybe ABCL, VTYX

Ok-Adeptness2257

My current portfolio, M37. RR - 83% (pre covid buy, slowly reducing) VWRA - 11% (increasing) IAG - 1.5% (hold, small dividend growing) QQQI - 1.3% (drip) SPYI - 1.3% (drip) ABCL - 0.5% (speculative buy, hold) BTCI - 0.4% (drip) KSPI - 0.4% (speculative buy, hold)

tke248

|Category|Winner|Insight| |:-|:-|:-| |Business Model|**ABCL**|Capital-light, partner-centric| |Data/Tech Moat|**RXRX**|Hardest-to-replicate dataset| |Revenue Visibility|**ABCL**|Milestones + royalties| |Long-term Upside|**RXRX**|If platform works → giant outcome| |Risk Level|**RXRX (high)**|Most speculative| |Financial Strength|**ABCL**|More runway, less burn|

Jasmine7707

ABCL big insider buy

1see2eat

ABCL, IOVA, MRNA. AI is imploding; get into BIO y’all. 

Asleep-Syllabub1316

No, leverage doesn’t cost some of the initial investment. They may have an Expense Ratio. But it should not be a lot. You need to research a bit about how leveraged stocks/ETF behave. There is something called as “time decay” Imagine you have a stock of ABC company at 100$ today. And a 2X leveraged of that same stock. Let’s call it ABCL and is also trading at 100$ Let’s say ABC stock goes down 40% today. ABC is now trading at 60$ But, ABCL will go down 80%. ABCL will now trade at 20$. Next day, imagine: ABC stock goes up 66%. Which means ABCL will go up 132% (2X) Now, ABC is 60$ * 1.66 (66%) =$99.60 (back to original price) But, ABCL is 20$ * 2.32 (132%) = $46.40 ABC is back to 100$ ABCL is still at 46.40$ This is how leveraged stocks work. You can lose a lot if the stock goes down and up a lot.

ralphy1010

yeah, i run similar, my 401 goes to the fidelity version of spy and the ira/roth are mainly voo/vgt with a newer NATO etf i've been buying and then various stocks like RKLB, LTBR, ABCL, NVIDIA and the sort that I've picked up along the way

pinksugi

Good take. $ABCL has real fundamentals. I’ve been using tickr-bio to track biotech events lately, it’s actually pretty useful for stuff like this.

Academic-News7204

Good take. $ABCL has real fundamentals. I’ve been using TICKR-BIO to track biotech catalysts lately, it’s actually pretty useful for stuff like this.

uninflammable

I did this a couple months or so ago on ABCL, got $5 calls out to January. Wish I remembered what the company does

Equal_Motor8568

Thoughts on RKT & ABCL ? ABCL fluctuates like a patient on bipolar medication RKT pissing all over my portfolio

zamo0273

Reminds me a lot of ABCL which hit a 52 week high last week

PotStonk

Been doing well off HOVR, GEVO, ABCL

brbsara

Shout out to OP for earlier contributions. Comparing **IRWD vs ABCL** risk/reward (used LLM as well). What am I overlooking in ABCL? # IRWD – Upside Case * **Close**: $1.43 * **Fair value**: \~$2.10 (DCF on royalty stream) → **\~47% upside** * **Q2 Highlights**: * LINZESS rev $85.7M, adj. EBITDA $50.1M, net income $23.6M * Cash $93M vs. \~$199M notes due 2026 * 2025 guide: rev $260–290M, EBITDA >$105M * **Valuation**: \~$120M FCF/yr, discounted over 6 yrs → \~$2.10/sh equity “floor” * **Risks**: optimistic FCF conversion, royalty erosion, working capital drag, unmodeled liabilities # ABCL – Snapshot * Rev $17.1M, R&D $39M, net loss –$34.7M * Liquidity \~$753M (cash + funding) * No stable cash flow; valuation tied to pipeline progress & clinical milestones **Contrast**: IRWD = royalty “floor” undervalued \~47% upside; ABCL = strong cash but pure pipeline risk.

Few-Passenger4404

Any thoughts in here on ABCL or RUM?

version-two

I’ve had this on a watchlist for 4 months. No news and 3x volume today… Unless someone has the scoop, I’m wondering if it’s being pulled up by the PFE jet stream. a lot of bio tech and healthcare seemed to move over the last 48 hours on the Pfizer news. $NTLA, $ABCL, $NUVB (yesterday), $MRNA, $NVAX, $MERCK… all up.

mamegan

sometimes you just have to buy a stock and let it sit, ABCL is one of the few stocks in the green today and i wasn’t expecting it

mcrash85

$ABCL + $BBAI and relax

LittleBunnyLongLeg

No. I just gave it a shot. Like ABCL.

mamegan

ABCL out of penny stock land 🥹 so proud

mcrash85

$ABCL $GRAB open your eyes mates!<3

mamegan

ABCL doing good as well

shaqballs

ABCL

Win108

ABCL

shaqballs

ATCH is this subs current darling, it’s done well but the minute it tanks everyone here will be acting like they all knew it was coming. Pump and dumps are fine if you know and can handle the risks but if you want real possible penny stocks investments I’ve got a few im watching. - HGRAF (I am balls deep on this one. Pre revenue highly speculative graphene company. Tons of risk as there always is with penny stocks but it could be one of those life changing stocks that you can get into before it blows up to unbelievable levels. - RR Robotics company with massive upside - PNG, Kraken Robotics. Fun little Canadian company that won’t be little for long. Defence and had close ties and contracts to Anduril which is a giant. - ABCL. A long term bio company that could be huge. People claim it is the palantir of biotech because of how they leverage AI to make money on finding antibodies for other companies. Also developing two of their own drugs. Royalties will be the big money maker but this is a very long term hold as in 3-5 years +

mamegan

ABCL up almost 10% today but I can’t find out why

Few-Passenger4404

What do people here think about SLDP, RUM & ABCL ?